Press Releases

March 31st, 2025

ROSELLA GOG-3073 | ENGOT-OV72
Corcept Therapeutics Incorporated Press Release
Read More arrow icon

March 27th, 2025

Sutro Biopharma Press Release
Read More arrow icon

March 14th, 2025

Faeth Therapeutics & The GOG Foundation, Inc.
GOG-3111 Trial Press Release
Read More arrow icon

December 11th, 2024

GOG-3086 (REFRaME-01) Press Release
Read More arrow icon

April 16th, 2024

SGO/GOG-F Launch BRIDGES 2.0 Research Initiative
Read More arrow icon

August 1st, 2023

Thomas J. Herzog, MD takes office as The GOG Foundation, Inc. President
Read More arrow icon

March 27th, 2023

ENGOT-EN6-NSGO/GOG-3031/RUBY Trial Results Press Release
Read More arrow icon

March 25th, 2023

GOG 3026 Press Release
Read More arrow icon

February 3rd, 2023

NRG-GY018 Press Release
Read More arrow icon

March 31st, 2022

GOG 3020 (ATHENA) /ENGOT-ov45 trial (ATHENA-MONO) Press Release
Read More arrow icon
Showing posts 1 - 10 of 51.